Home > Analytics > BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Intrinsic Value | Fundamental Analysis

BOM : 524663     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Feb 08,2023
Price(EOD): ₹ 24.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 105.19 Cr
Value of ₹ 1 Lac invested in BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
on Feb 08,2018 (price: ₹ 24.30)

₹ 1 L

₹ 1.00 L

1W : -4.1% 1M : -18.2% 1Y : -49.5%
COMMUNITY POLL
for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION -4.1% -18.2% -49.5%
SUN PHARMACEUTICAL INDUSTRIES 0.5% -0.1% 12.5%
DIVIS LABORATORIES -14.3% -19.1% -36.2%
CIPLA 1.4% -4.4% 9%
DR REDDYS LABORATORIES 2.7% 3.5% 2.1%
TORRENT PHARMACEUTICALS 1% -0.4% 14.4%
ABBOTT INDIA 3.8% -4.4% 32%
ZYDUS LIFESCIENCES 9.6% 7% 17.2%
ALKEM LABORATORIES 3.4% 4.1% -12.8%

FUNDAMENTAL ANALYSIS OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

 
Fundamentals Score
[ Q(TTM): Sep2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

 
Valuation Score
[As on : Feb 08,2023 ]

Ratio Standalone
P/E
P/B
P/S
-5.92
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -17.77 Cr
[Latest Qtr - Sep2022 - Standalone Results ]

1
P/B Calculated based on Book Value of Rs 105.35 Cr
[Latest Year - Mar2022 - Standalone Results ]

1.33
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2022 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 29% undervalued companies ! Discover More →

FAIR VALUE OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
NA (-ve EV)
-19%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION



BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
-12.18
11.56
0.15
-0.16
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Pledged Promoter Shares
0 %
As on : Dec2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
152.7%
48.24%
37.19%
38.29%
86.28%
-340.62%
-5450%
-259.99%
QtrlyTrend
2
Latest Qtr: Sep2022
Quarterly Result Analysis →


BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION


Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION good for long term investment?

As on Feb 08,2023, the Fundamentals of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION look Poor and hence it may not be good for long term investment ! See Financial Performance of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION UnderValued or OverValued?

As on Feb 08,2023, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?

As on Feb 08,2023, the Intrinsic Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is Rs. 30.02 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -18.68
Fair Value [Median EV / Sales Model] : Rs. -0.18
Fair Value [Median Price / Sales Model] : Rs. 30.02
Estimated Median Fair Value of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION : Rs. 30.02

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION trading at a Premium or Discount?

As on Feb 08,2023, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is trading at a Discount of -19% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].